The global demand for Fluorine-18 Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Fluorine-18 (18F) is a radioisotope of fluorine that emits many positrons. It is primarily created via proton irradiation of a stable isotope of 18 O with a cyclotron. In clinical operations, fluorine-18 is the most often utilized radioisotope in positron emission tomography (PET) radiopharmaceuticals. Because of its excellent sensitivity and spatial resolution, Fluorine-18 is a non-invasive imaging approach that can reliably quantify the concentration of the tracer in tissues. Because of its physical and nuclear properties, high distinct activity, and ease of large-scale manufacture, radiochemical labeling and molecular imaging appear more appealing. The growing use of fluorine-18 radiotracers for PET imaging underscores the need for 18F-labeling techniques that are simple and efficient.
Market Dynamics
PET and PET/CT systems are increasingly being employed to identify and treat various essential illnesses, including cardiovascular, neurology-related, and cancer. As a result, the worldwide fluorine-18 market is likely to benefit from increasing the frequency of PET/CT scans. The global fluorine-18 market is being driven by an increase in fluorine-18 in various industries. Fluorine-18 has low positron energy, a high positron-to-decay ratio, and a short half-life. It is rapidly being employed in the radiochemistry sector due to these features. The global fluorine-18 market is growing as a result of this cause.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of fluorine-18. The growth and trends of fluorine-18 industry provide a holistic approach to this study.
Market Segmentation
This section of the fluorine-18 market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By End User
- Hospitals
- Diagnostic Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Fluorine-18 market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Fluorine-18 Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the fluorine-18 market include Siemens Healthineers, Lantheus Holdings, Inc., GE Healthcare (General Electric Company), Advanced Accelerator Applications (a Novartis AG Company), Jubilant Pharma Limited, Blue Earth Diagnostics (A Bracco Imaging Company), Eli Lilly and Company, China lsotope & Radiation Corporation, Yantai Dongcheng Pharmaceutical Group Co., Ltd., Curium Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
